As a result, the expression of selected IBS genetic biomarkers (TPH1) was shown to be modulated by vitamin D. The results of that study suggest that IBS pathogenesis and pathophysiology may be involved in dysregulation of serotonin production and vitamin D insufficiency (Dussik et al., 2018[14]). Here, TPH1 is linked to irritable bowel syndrome.